Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection

Infection and Immunity

Volumn 71, Issue 5, 2003, Pages 2744-2757

  Boscardin, Silvia B ^a   Kinoshita, Sheila S ^a   Fujimura, Adriana E ^a   Rodrigues, Mauricio M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMASTIGOTE SURFACE PROTEIN 2; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; DNA VACCINE; GAMMA INTERFERON; PARASITE ANTIGEN; POLYCLONAL ANTISERUM; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CHAGAS DISEASE; CLONE 9 GENE; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL INFECTION; FEMALE; GENE; IMMUNE RESPONSE; IMMUNIZATION; LETHALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE DEVELOPMENT; PARASITEMIA; PLASMID; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE; TH1 CELL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; DNA, COMPLEMENTARY; FEMALE; IMMUNE SERA; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 0037408506     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.5.2744-2757.2003     Document Type: Article

References (47)

1. Allen, C. L., and J. M. Kelly. 2001. Trypanosoma cruzi: mucin pseudogenes organized in a tandem array. Exp. Parasitol. 97:173-177.
2. Cano, M. I., A. Gruber, M. Vazquez, A. Cortes, M. J. Levin, A. Gonzalez, W. Degrave, E. Rondinelli, B. Zingales, J. L. Ramirez, C. Alonso, J. M. Requena, and J. Franco da Silveira. 1995. Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project. Mol. Biochem. Parasitol. 71:273-278.
3. d exploits a four residue peptide binding motif. J. Exp. Med. 178:1877-1892.
4. ds: sequence motif, quantitative binding, and molecular modeling of the complex. J. Exp. Med. 176:1681-1692.
5. Costa, F., G. Franchin, V. L. Pereira-Chioccola, M. Ribeirão, S. Schenkman, and M. M. Rodrigues. 1998. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16:768-774.
6. Cross, G. A., and G. B. Takle. 1993. The surface trans-sialidase family of Trypanosoma cruzi. Annu. Rev. Microbiol. 47:385-411.
7. Falk, K., O. Rotzschke, K. Dres, J. Metzger, G. Jung, and H.-G. Rammensee. 1991. Identification of naturally processed viral nonapeptide allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425-434.
8. Fouts, D. L., B. J. Ruef, P. T. Ridley, R. A. Wrightsman, D. S. Peterson, and J. E. Manning. 1991. Nucleotide sequence and transcription of a trypomastigote surface antigen gene of Trypanosoma cruzi. Mol. Biochem. Parasitol. 46:189-200.
9. + T cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 69:5477-5486.
10. Garg, N., and R. Tarleton. 2002. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70:5547-5555.
11. Hoft, D. F., and C. S. Eickhoff. 2002. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect. Immun. 70:6715-6725.
12. Hoft, D. F., A. R. Schnapp, C. S. Eickhoff, and S. T. Roodman. 2000. Involvement of CD4 Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect. Immun. 68:197-204.
13. Hölscher, C., G. Kölher, U. Müller, H. Mossman, G. A. Schaub, and F. Brombacher. 1998. Defective nitric oxide effector function lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66:1208-1215.
14. Ishioka, G. Y., J. Fikes, G. Hermanson, B. Livingston, C. Crimi, M. Qin, M. F. del Guercio, C. Oseroff, C. Dahlberg, J. Alexander, R. W. Chesnut, and A. Sette. 1999. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162:3915-3925.
15. Jou, W. M., M. Verhoeyen, R. Devos, E. Saman, R. Fang, D. Huylebroeck, W. Fiers, G. Threlfall, C. Barber, N. Carey, and S. Emtage. 1980. Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA. Cell 19:683-696.
16. Kahn, S., M. Wleklinski, A. Aruffo, A. Farr, D. Coder, and M. Kahn. 1995. Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor. J. Exp. Med. 182:1243-1258.
17. Krettli, A. U., and Z. Brener. 1976. Protective effects of specific antibodies in Trypanosoma cruzi infections. J. Immunol. 116:755-760.
18. Kumar, S., and R. L. Tarleton. 2001. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J. Immunol. 166:4596-4603.
19. + CTL. J. Immunol. 160:1817-1823.
20. Low, H. P., and R. L. Tarleton. 1997. Molecular cloning of the gene encoding the 83 kDa amastigote surface protein and its identification as a member of the Trypanosoma cruzi sialidase super-family. Mol. Biochem. Parasitol. 88: 137-149.
21. Magdesian, M. H., R. Giordano, H. Ulrichi, M. A. Juliano, L. Juliano, R. I. Schumacher, W. Colli, and M. J. M. Alves. 2001. Infection by Trypanosoma cruzi: identification of a parasite ligand and its host cell receptor. J. Biol. Chem. 276:19382-19389.
22. Martins, G. A., S. B. Petkova, F. S. Machado, R. N. Kitsis, L. M. Weiss, M. Wittner, H. B. Tanowitz, and J. S. Silva. 2001. Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. Immunology 103:122-129.
23. Medina-Acosta, E., and G. A. M. Cross. 1993. Rapid isolation of DNA from trypanosomatid protozoa using a simple "mini-prep" procedure. Mol. Biochem. Parasitol. 59:327-330.
24. Michailowsky, V., N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli. 2001. Pivotal role of interleukin-12 and interferongamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 159:1723-1733.
25. Miyahira, Y., K. Murata, D. Rodriguez, J. R. Rodriguez, M. Esteban, M. M. Rodrigues, and F. Zavala. 1995. Quantification of antigen specific CD8+ T cells using ELISPOT assay. J. Immunol. Methods 181:145-154.
26. Pan, A. A., and D. McMahon-Pratt. 1989. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein. J. Immunol. 143:1001-1008.
27. Peterson, D. S., R. A. Wrightsman, and J. E. Manning. 1986. Cloning of a major surface-antigen gene of Trypanosoma cruzi and identification of a nonapeptide repeat. Nature 322:566-568.
28. Planelles, L., M. C. Thomas, C. Alonso, and M. C. Lopez. 2001. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect. Immun. 69:6558-6563.
29. Rodrigues, M., S. Li, K. Murata, D. Rodriguez, J. R. Rodriguez, I. Bacik, J. R. Bennink, J. W. Yewdell, A. Garcia-Sastre, R. S. Nussenzweig, M. Esteban, P. Palese, and F. Zavala. 1994. Influenza and vaccinia virus expressing malaria CD8 T and B cell epitopes: comparison of their immunogenicity and capacity to induce protective immunity against malaria. J. Immunol. 153:4636-4649.
30. Rodrigues, M. M., M. Ribeirão, V. Pereira-Chioccola, L. Renia, and F. Costa. 1999. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect. Immun. 67:3855-3863.
31. Rodrigues, M. M., M. Ribeirão, and S. B. Boscardin. 2000. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunol. Lett. 73:43-50.
32. Rottenberg, M. E., M. Bakhiet, T. Olsson, K. Kristensson, T. Mak, H. Wigzell, and A. Orn. 1993. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61:5129-5133.
33. Ruef, B. J., B. D. Dawson, D. Tewari, D. L. Fouts, and J. E. Manning. 1994. Expression and evolution of members of the Trypanosoma cruzi trypomastigote surface antigen multigene family. Mol. Biochem. Parasitol. 63:109-120.
34. Ruef, B. J., and J. E. Manning. 1993. Isolation and characterization of the TSA/trans-sialidase family gene from the Silvio strain of Trypanosoma cruzi. Mol. Biochem. Parasitol. 62:117-120.
35. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York, N.Y.
36. Santos, A. M., N. Garg, and R. L. Tarleton. 1997. The identification and molecular characterization of Trypanosoma cruzi surface protein-1, a member of the trans-sialidase gene super-family. Mol. Biochem. Parasitol. 86:1-11.
37. Schnapp, A. R., C. S. Eickhoff, D. Sizemore, R. Curtiss III, and D. F. Hoft. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect. Immun. 70:5065-5074.
38. Sepulveda, P., M. Hontebeyrie, P. Liegeard, A. Mascilli, and K. A. Norris. 2000. DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Infect. Immun. 68:4986-4991.
39. Sheffield, P., S. Garrard, and Z. Derewenda. 1999. Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expr. Purif. 15:34-39.
40. Silva, J. S., P. J. Morrisey, K. H. Grabstein, K. M. Moller, D. Anderson, and S. G. Reed. 1992. Interleukin 10 and-interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169-174.
41. Silva, L. H. P., and V. Nussenzweig. 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 20: 191-203.
42. Tarleton, R. L., M. J. Grusby, and L. Zhang. 2000. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J. Immunol. 165:1520-1525.
43. Tarleton, R. L. 1995. The role of T cells in Trypanosoma cruzi infection. Parasitol. Today 11:7-12.
44. Vespa, G. N., F. Q. Cunha, and J. S. Silva. 1994, Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:5177-5182.
45. Wizel, B., N. Garg, and R. Tarleton. 1998. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:5073-5081.
46. + TC1 responses. J. Immunol. 159:6120-6130.
47. Wizel, B., M. Palmieri, C. Mendoza, B. Arana, J. Sidney, A. Sette, and R. L. Tarleton. 1998. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J. Clin. Investig. 102: 1062-1071.